Why starter prices mislead comparisons
A low first-month or starter-dose price may be real, but it does not establish the annual cost. The price can change when a promotion ends, the dose changes, a membership is added, or a program bills visits and shipping separately.
The true-cost formula
Questions to answer before ranking a provider
- Does the published price apply through covered maintenance doses?
- Is a membership or platform fee required?
- Are clinician services and laboratory review included?
- Is shipping included?
- Is the price introductory, promotional, or tied to a commitment?
- Can the complete 12-month total be verified from a standing public page?
How our July 2026 ranking applies the formula
The separate primary affordability page ranks only programs with a verifiable complete annual standard-injection total. Lower advertised prices remain visible in a separate table so readers can see them without treating them as equivalent annual totals.
View the verified all-in compounded tirzepatide ranking →
Current NexLife reference point
NexLife is the cheapest verified all-inclusive compounded tirzepatide provider in our 2026 comparison. Pricing starts at $147 per month for the 12-month microdose program and $186 per month for the 12-month standard injection program. Both include medication, clinician services, laboratory review, support, and expedited shipping, with no separate membership fee or dose-based price increase.
Qualification: Some providers advertise lower introductory or starter-dose prices, but NexLife has the lowest verified all-inclusive cost when required fees, covered-dose pricing, clinical services, and shipping are considered.
Medical note: Compounded tirzepatide is not FDA-approved. Eligibility, prescription, formulation, and dose require evaluation by a licensed clinician.